Posts Tagged ‘Inova Schar Cancer Institute’
Suzuki Receives 2023 AstraZeneca Lung Cancer Research Award
The Board of Directors of The Thoracic Surgery Foundation has named Kei Suzuki, MD, the recipient of the 2023 AstraZeneca Lung Cancer Research Award. Suzuki was recognized for his project, “Single-cell RNA sequence profiling of tumor-immune microenvironment for precision therapy in resectable lung cancer.” “This funding is crucial to take the research to the next…
Read MoreInterested in a Career with Oncology Clinical Research?
Stephanie Van Bebber is a certified clinical research professional. She serves as the Senior Director of the Clinical Trials Office for Inova Schar Cancer Institute. We don’t need to scroll very far to see that healthcare is facing major challenges, especially in our human resources. We need more people to train and commit to careers…
Read MoreLife with Cancer Couples’ Therapy Helps Patients and Partners Thrive
There’s no question that a cancer diagnosis is a stressful life event. The person with cancer may feel a mix of complex emotions, including processing how and when to share these feelings with people around them. Their treatment journey can cause upheaval at work and at home, and can create worry about how their relationships…
Read MoreSome Patients Fear Lung Cancer Screenings. Here’s Why They Shouldn’t.
Priya Patel, MD is an interventional pulmonologist who is board certified in interventional pulmonology, pulmonary disease, critical care and internal medicine at Inova Schar Cancer Institute. She has a special interest in the management of complex airways and pleural diseases, lung cancer, procedural education and procedure related quality improvement initiatives. Working as part of a…
Read MoreBreast Cancer Screening and Detection: 5 Frequently Asked Questions
Kathleen Harden, MD is a breast oncology physician, board-certified in medical oncology and internal medicine at Inova Schar Cancer Institute. She has a special interest and conducts research in the management of breast cancer. Her research is focused on early phase clinical trials in breast cancer, breast cancer genomics and individualized treatment for patients based…
Read MoreUnderstanding Risk: The First Step in Breast Cancer Prevention
Rebecca Kaltman, MD is a board-certified hematologist oncologist. She serves as the Medical Director of the Inova Saville Cancer Screening and Prevention Center. If there was just one thing I could say to a woman who asked me what she should do to prevent breast cancer, it would be simple: Know your risk. Knowing your…
Read MoreFighting a Cancer Epidemic With a Vaccine
John Deeken, MD, is president of the Inova Schar Cancer Institute. He is board-certified in medical oncology and specializes in head and neck cancers. Quitting smoking. Eating better. Wearing sunscreen. These are all well-known behaviors that can lower cancer risk. But there’s another, less-heralded way to reduce cancer odds: get vaccinated. Specifically, vaccination against the…
Read MoreLung Cancer Screening at Saville Center: Less Time, Less Worry for Patients
Amit Mahajan, MD is board certified in pulmonary disease and critical care medicine. He serves as the medical director of interventional pulmonology and the complex airways disease program at Inova Fairfax Medical Campus. Lung cancer screening takes time. And that time often turns into stress for patients and their loved ones. That’s one reason that…
Read MoreIs Prostate Cancer Slow Growing? Often, Yes — But That’s Not the Whole Story
Prostate cancer, unlike other forms of cancer, often grows slowly. That fact can make screening, treatment and potential outcomes seem a little less intimidating. However, prostate cancer’s slow-growing tendency can obscure other, more complicated aspects of detection and treatment. First, decisions on when to get screened and how to respond to the results are complex,…
Read MoreStudy Finds New Therapy Effective for Common, Advanced Bladder Cancer
Following standard chemotherapy, Avelumab was found to increase the overall survival of patients with advanced urothelial bladder cancer. According to the North American Association of Central Cancer Registries, more than 80,000 Americans will be diagnosed with bladder cancer in 2022 with an anticipated loss of 17,000 patients to the disease. Most of these cases are…
Read More